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Background: The soluble receptor for advanced glycation end products (sRAGE) participates in the pathogenesis of vascular disease, while 
subclinical inflammatory processes and increased asymmetric dimethylarginine (ADMA) levels are related to atherosclerosis progression. In the 
present study, we investigated the relationships of sRAGE with ADMA and high-sensitivity C-reactive protein (hs-CRP) in essential hypertensives.
Methods: Our population consisted of 80 newly diagnosed untreated non-diabetic patients with stage I to II essential hypertension [48 men, 
mean age=52 years, office blood pressure (BP)=145/93 mmHg]. In all participants, venous blood sampling was performed to estimate hs-CRP and 
sRAGE levels. The distribution of sRAGE was split by the median (1060.3 pg/ml) and accordingly subjects were stratified into those with high and low 
values.
Results: Patients with low sRAGE (n=41) compared to those with high sRAGE values (n=39) had greater body mass index (29.8±4.6 vs 27.2±2.9 
kg/m2, p<0.05) and 24-h systolic BP (138±10 vs 131±7 mmHg, p=0.001), while did not differ regarding metabolic profile (p=NS for all). Moreover, 
patients with low sRAGE compared to those with high sRAGE levels exhibited higher hs-CRP (4.8±2.4 vs 2.4±1.9 mg/l, p<0.0001) and ADMA 
(0.58±0.06 vs 0.52±0.04 μmol/l, p<0.0001), independently of confounders. In the total population, sRAGE was associated with body mass index 
(r=-0.241, p=0.003), waist to hip ratio (r=-0.463, p<0.0001), 24-h pulse pressure (r=-0.372, p=0.001), hs-CRP (r=-0.292, p=0.012) and ADMA 
(r=-0.355, p=0.002). Regarding ADMA, it was related to 24-h systolic BP (r=0.491, p<0.0001) and PWV (r=0.487, p<0.0001). Multiple regression 
analysis revealed that body mass index, 24-h systolic BP, hs-CRP and ADMA were the independent predictors of sRAGE (R2=0.51, p<0.0001).
Conclusion: In essential hypertension, decreased sRAGE levels are associated with pronounced inflammatory activation and endothelial 
dysfunction, as reflected by increased hs-CRP and ADMA levels. Moreover, the relation of sRAGE with hs-CRP and ADMA, underscores the emerging 
role of this receptor in the progression of vascular atherosclerosis in the hypertensive setting.
